?
Взаимосвязь генотипа главного комплекса гистосовместимости класса I с летальностью COVID-19 у пациентов с сахарным диабетом
Numerous studies have shown that diabetes mellitus (DM) increases the risk of death from COVID-19 by five
times. It is generally accepted that the high lethality of COVID-19 against the background of DM is due to
the main complications of this disease: micro- and macroangiopathies, heart and kidney failure. In addition,
it has been shown that acute respiratory viral infection increases interferon-gamma production and muscle
resistance to insulin, modulating the activity of effector CD8+ T-lymphocytes. The ability of CD8+ T lym-
phocytes to recognize SARS-CoV-2 infected cells depends on the individual set of major histocompatibility
complex class I (MHC-I) molecules. In this study, on a sample of 222 patients, the association of the MHC-
I genotype of patients with diabetes aged less than 60 years with the outcome of COVID-19 was studied. It
has been shown that lethal outcomes of COVID-19 in patients with DM are associated with the low affinity
of the interaction of an individual set of MHC-I molecules with SARS-CoV-2 peptides.